Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Jaqui Walker; Marco Cattaneo; Lina Badimon; Giancarlo Agnelli; Andrew T. Chan; Angel Lanas; Bianca Rocca; Peter Rothwell; Paola Patrignani; Ruth Langley; Gemma Vilahur; Francesco Cosentino

doi:10.3332/ECANCER.2019.998

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Jaqui Walker, Marco Cattaneo, Lina Badimon, Giancarlo Agnelli, Andrew T. Chan, Angel Lanas, Bianca Rocca, Peter Rothwell, Paola Patrignani, Ruth Langley, Gemma Vilahur, Francesco Cosentino

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.

Lingua originale	English
pagine (da-a)	1-13
Numero di pagine	13
Rivista	ecancermedicalscience
Volume	14
DOI	https://doi.org/10.3332/ECANCER.2019.998
Stato di pubblicazione	Pubblicato - 2020

Keywords

anticoagulant
antiplatelet
antithrombotic
aspirin
benefit
cardiovascular disease (CVD)
colorectal cancer (CRC)
diabetes mellitus (DM)
gastroprotectant agents
optimizing aspirin dose
precision medicine
primary prevention
risk
secondary prevention
targeting
upper gastrointestinal (GI) bleeding

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3332/ECANCER.2019.998

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Walker, J., Cattaneo, M., Badimon, L., Agnelli, G., Chan, A. T., Lanas, A., Rocca, B., Rothwell, P., Patrignani, P., Langley, R., Vilahur, G., & Cosentino, F. (2020). Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention. ecancermedicalscience, 14, 1-13. https://doi.org/10.3332/ECANCER.2019.998

@article{008c7690372646ee8128220524202bd3,

title = "Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention",

abstract = "At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.",

keywords = "anticoagulant, antiplatelet, antithrombotic, aspirin, benefit, cardiovascular disease (CVD), colorectal cancer (CRC), diabetes mellitus (DM), gastroprotectant agents, optimizing aspirin dose, precision medicine, primary prevention, risk, secondary prevention, targeting, upper gastrointestinal (GI) bleeding, anticoagulant, antiplatelet, antithrombotic, aspirin, benefit, cardiovascular disease (CVD), colorectal cancer (CRC), diabetes mellitus (DM), gastroprotectant agents, optimizing aspirin dose, precision medicine, primary prevention, risk, secondary prevention, targeting, upper gastrointestinal (GI) bleeding",

author = "Jaqui Walker and Marco Cattaneo and Lina Badimon and Giancarlo Agnelli and Chan, {Andrew T.} and Angel Lanas and Bianca Rocca and Peter Rothwell and Paola Patrignani and Ruth Langley and Gemma Vilahur and Francesco Cosentino",

year = "2020",

doi = "10.3332/ECANCER.2019.998",

language = "English",

volume = "14",

pages = "1--13",

journal = "ecancermedicalscience",

issn = "1754-6605",

publisher = "Cancer Intellilgence",

}

Walker, J, Cattaneo, M, Badimon, L, Agnelli, G, Chan, AT, Lanas, A, Rocca, B, Rothwell, P, Patrignani, P, Langley, R, Vilahur, G & Cosentino, F 2020, 'Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention', ecancermedicalscience, vol. 14, pagg. 1-13. https://doi.org/10.3332/ECANCER.2019.998

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention. / Walker, Jaqui; Cattaneo, Marco; Badimon, Lina et al.
In: ecancermedicalscience, Vol. 14, 2020, pag. 1-13.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

AU - Walker, Jaqui

AU - Cattaneo, Marco

AU - Badimon, Lina

AU - Agnelli, Giancarlo

AU - Chan, Andrew T.

AU - Lanas, Angel

AU - Rocca, Bianca

AU - Rothwell, Peter

AU - Patrignani, Paola

AU - Langley, Ruth

AU - Vilahur, Gemma

AU - Cosentino, Francesco

PY - 2020

Y1 - 2020

N2 - At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.

AB - At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.

KW - anticoagulant

KW - antiplatelet

KW - antithrombotic

KW - aspirin

KW - benefit

KW - cardiovascular disease (CVD)

KW - colorectal cancer (CRC)

KW - diabetes mellitus (DM)

KW - gastroprotectant agents

KW - optimizing aspirin dose

KW - precision medicine

KW - primary prevention

KW - risk

KW - secondary prevention

KW - targeting

KW - upper gastrointestinal (GI) bleeding

KW - anticoagulant

KW - antiplatelet

KW - antithrombotic

KW - aspirin

KW - benefit

KW - cardiovascular disease (CVD)

KW - colorectal cancer (CRC)

KW - diabetes mellitus (DM)

KW - gastroprotectant agents

KW - optimizing aspirin dose

KW - precision medicine

KW - primary prevention

KW - risk

KW - secondary prevention

KW - targeting

KW - upper gastrointestinal (GI) bleeding

UR - http://hdl.handle.net/10807/147317

U2 - 10.3332/ECANCER.2019.998

DO - 10.3332/ECANCER.2019.998

M3 - Article

SN - 1754-6605

VL - 14

SP - 1

EP - 13

JO - ecancermedicalscience

JF - ecancermedicalscience

ER -

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo